A new study may provide a novel tool for detection of malignant-stage ovarian cancer. Researchers found that positron emission tomography and computed tomography (PET/CT), which images both functional and anatomical changes in the body, was useful for preoperative cancer imaging of ovarian masses when used with a radiotracer that is actively metabolized by cells as fuel. Physicians imaging patients suspected of having malignant tumors can see where cancerous cells are hyper-metabolizing the tracer and accurately predict whether a mass is malignant, cancerous but stable, or benign.
- PET imaging determines malignancy in potential ovarian cancer casesMon, 6 Jun 2011, 13:38:30 EDT
- PET/CT scan could be valuable noninvasive tool for determining stages of ovarian cancerMon, 16 Jun 2008, 12:49:33 EDT
- True whole-body field view using PET/CT could allow doctors to more accurately manage cancer patientsMon, 22 Nov 2010, 12:11:42 EST
- Nationwide study confirms PET as the most powerful imaging tool in cancer managementMon, 1 Dec 2008, 11:22:56 EST
- Combining CT, FDG-PET provides more accurate treatments for head and neck cancer patientsFri, 29 Apr 2011, 8:33:34 EDT